Vote Scores
Filings read through

CRISPR THERAPEUTICS AG: how funds voted at the meeting of 30 May 2024

Ticker
CRSP
Meeting
Season
year to 30 June 2024
Filers reporting
538
Ballot items
7

538 filers on Form N-PX reported votes at the CRISPR THERAPEUTICS AG meeting of 30 May 2024. The records fall into 7 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of CRISPR THERAPEUTICS AG has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    14 nominees. 70.6% of the reported votes are for. 74 filers withheld from or voted against at least one nominee.

    2,036 vote records from 96 filers. 20 of the 90 filers that marked the item voted against management. 6 filers gave no management mark.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 32 fund families
    • For 23
    • Against 9
    • Against management 9
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    804 vote records from 525 filers. 234 of the 480 filers that marked the item voted against management. 45 filers gave no management mark.

    One filer reported a share count too large for the holding. The site publishes no share split for this item. The rule

    • Positions of 41 fund families
    • For 16
    • Against 25
    • Against management 25
  3. Item 3: Audit-related items (auditor ratification)

    162 vote records from 95 filers. 3 of the 89 filers that marked the item voted against management. 6 filers gave no management mark.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 32 fund families
    • For 31
    • Against 1
    • Against management 1
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    372 vote records from 92 filers. 1 of the 86 filers that marked the item voted against management. 6 filers gave no management mark.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 32 fund families
    • For 32
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    1,448 vote records from 154 filers. 48 of the 145 filers that marked the item voted against management. 9 filers gave no management mark.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 32 fund families
    • For 18
    • Against 14
    • Against management 14
  6. Item 6: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    780 vote records from 93 filers. 6 of the 87 filers that marked the item voted against management. 6 filers gave no management mark.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 32 fund families
    • For 30
    • Against 2
    • Against management 2
  7. Item 7: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    144 vote records from 27 filers. 1 of the 25 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 5 fund families
    • For 3
    • Split or no vote 2

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at CRISPR THERAPEUTICS AG, meeting of 30 May 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinAgainst, against managementNo report
AllspringAgainst, against managementFor
American BeaconForFor
American CenturyAgainst, against managementFor
BairdAgainst, against managementNo report
BlackRock and iSharesAgainst, against managementFor
BNY MellonAgainst, against managementNo report
Brighthouse FundsAgainst, against managementFor
Capital Group and American FundsForFor
Charles SchwabAgainst, against managementFor
DimensionalAgainst, against managementFor
EquitableForFor
Federated HermesForFor
FidelityAgainst, against managementFor
First TrustAgainst, against managementFor
Franklin TempletonAgainst, against managementFor
Global XAgainst, against managementFor
Goldman SachsForFor
Guggenheim and RydexAgainst, against managementFor
InvescoAgainst, against managementFor
J.P. MorganForFor
Jackson National fundsForFor
John Hancock and ManulifeAgainst, against managementFor
Lincoln FinancialForFor
MassMutualForFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementNo report
NationwideForFor
Natixis and Loomis SaylesForFor
Neuberger BermanAgainst, against managementNo report
Northern Trust and FlexSharesForFor
Nuveen and TIAAForNo report
PIMCOAgainst, against managementAgainst, against management
PrincipalAgainst, against managementNo report
ProShares and ProFundsAgainst, against managementFor
SEIAgainst, against managementNo report
State Street and SPDRForFor
T. Rowe PriceForFor
TransamericaAgainst, against managementFor
VanEckAgainst, against managementFor
VanguardForFor
VoyaAgainst, against managementNo report

Questions

How many filers reported votes at the CRISPR THERAPEUTICS AG meeting?
538 Form N-PX filers reported votes at the meeting of 30 May 2024. On say-on-pay, 234 of 480 filers that marked the item voted against management (48.8%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. CRISPR THERAPEUTICS AG reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list CRISPR THERAPEUTICS AG with a meeting date within three days of 30 May 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .